Working… Menu

CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00562419
Recruitment Status : Unknown
Verified October 2010 by Adnexus, A Bristol-Myers Squibb R&D Company.
Recruitment status was:  Active, not recruiting
First Posted : November 22, 2007
Last Update Posted : October 27, 2010
Information provided by:
Adnexus, A Bristol-Myers Squibb R&D Company

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2011
Estimated Study Completion Date : December 2011